The sale was for $256 million and is expected to be complete by the third quarter of this year, according to a Regeneron news ...

Regeneron acquires 23andMe for $256 million following its bankruptcy. The deal includes DNA data access, raising privacy ...

In March, 23andMe said that it was looking to sell “substantially all of its assets” through a court-approved reorganization plan.

Investors burned by President Trump’s trade fight now have to contend with a spending megabill that risks swelling the ...

Dow Jones Top Company Headlines at 5 AM ET: Chinese Battery Giant CATL’s Shares Surge on Hong Kong Debut | Honda ... The listing comes as risk appetite has returned to global markets as trade ...

Regeneron Pharmaceuticals said in a press release yesterday that it would acquire 23andMe’s Personal Genome Service (PGS), ...

Novavax Inc. (NVAX) shares jumped 15% after the company received a long-awaited U.S. FDA approval for its COVID-19 vaccine. Shares of Regeneron Pharmaceuticals, Inc. (REGN) rose 0.4% after deciding to ...

Bankrupt DNA testing company 23andMe was purchased Monday by biotechnology company Regeneron for $256 million. Both companies ...

Regeneron Pharmaceuticals Inc. (NASDAQ:REGN) announced Monday that it has secured the winning bid in the bankruptcy auction ...

Biotechnology company Regeneron agreed to buy the assets of 23andMe, the DNA testing company that filed for bankruptcy in March, for $256 million. That’s just 4% of the San Francisco-based startup’s ...